Meridian Bioscience, Inc. total revenue, net income and dynamics of changes in US dollar today
Net revenue of Meridian Bioscience, Inc. on 31/03/2021 amounted to 85 264 000 $. Net income of Meridian Bioscience, Inc. today amounted to 26 302 000 $. Here are the main financial indicators of Meridian Bioscience, Inc.. Schedule of the financial report of Meridian Bioscience, Inc. for today. The financial report chart on our website displays information by dates from 30/06/2017 to 31/03/2021. The value of "net income" Meridian Bioscience, Inc. on the graph is displayed in blue.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
85 264 000 $
+69.69 % ↑
26 302 000 $
+270.76 % ↑
31/12/2020
92 917 000 $
+95.94 % ↑
26 779 000 $
+847.26 % ↑
30/09/2020
64 153 000 $
+26.17 % ↑
6 493 000 $
+58.25 % ↑
30/06/2020
84 797 000 $
+75.06 % ↑
27 507 000 $
+441.58 % ↑
31/12/2019
47 421 000 $
-
2 827 000 $
-
30/09/2019
50 846 000 $
-
4 103 000 $
-
30/06/2019
48 440 000 $
-
5 079 000 $
-
31/03/2019
50 248 000 $
-
7 094 000 $
-
31/12/2018
51 480 000 $
-
8 106 000 $
-
30/09/2018
53 100 000 $
-
5 434 000 $
-
30/06/2018
51 737 000 $
-
6 825 000 $
-
31/03/2018
56 451 000 $
-
5 288 000 $
-
31/12/2017
52 283 000 $
-
6 302 000 $
-
30/09/2017
49 697 000 $
-
5 726 000 $
-
30/06/2017
50 140 000 $
-
240 000 $
-
Show:
to
Meridian Bioscience, Inc. financial report charts
Dates of Meridian Bioscience, Inc. finance reports: 30/06/2017, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest financial report of Meridian Bioscience, Inc. is available online for such a date - 31/03/2021. Gross profit Meridian Bioscience, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Meridian Bioscience, Inc. is 57 772 000 $
Meridian Bioscience, Inc. quarterly report dates
Cost of revenue Meridian Bioscience, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Meridian Bioscience, Inc. is 27 492 000 $ Total revenue Meridian Bioscience, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Meridian Bioscience, Inc. is 85 264 000 $ Operating income Meridian Bioscience, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Meridian Bioscience, Inc. is 32 242 000 $
Net income Meridian Bioscience, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Meridian Bioscience, Inc. is 26 302 000 $ Current assets Meridian Bioscience, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Meridian Bioscience, Inc. is 188 294 000 $ Total assets Meridian Bioscience, Inc. refers to the total amount of assets owned by a person or entity. Total assets Meridian Bioscience, Inc. is 439 169 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
57 772 000 $
61 548 000 $
38 502 000 $
55 852 000 $
27 440 000 $
29 156 000 $
28 259 000 $
29 338 000 $
31 572 000 $
32 150 000 $
31 956 000 $
34 569 000 $
31 786 000 $
30 655 000 $
31 197 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
27 492 000 $
31 369 000 $
25 651 000 $
28 945 000 $
19 981 000 $
21 690 000 $
20 181 000 $
20 910 000 $
19 908 000 $
20 950 000 $
19 781 000 $
21 882 000 $
20 497 000 $
19 042 000 $
18 943 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
85 264 000 $
92 917 000 $
64 153 000 $
84 797 000 $
47 421 000 $
50 846 000 $
48 440 000 $
50 248 000 $
51 480 000 $
53 100 000 $
51 737 000 $
56 451 000 $
52 283 000 $
49 697 000 $
50 140 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
47 421 000 $
50 846 000 $
48 440 000 $
50 248 000 $
51 480 000 $
53 100 000 $
51 737 000 $
56 451 000 $
52 283 000 $
49 697 000 $
50 140 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
32 242 000 $
36 938 000 $
12 029 000 $
30 409 000 $
7 176 000 $
7 563 000 $
8 916 000 $
11 223 000 $
11 140 000 $
11 686 000 $
10 816 000 $
9 131 000 $
9 544 000 $
8 807 000 $
10 932 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
26 302 000 $
26 779 000 $
6 493 000 $
27 507 000 $
2 827 000 $
4 103 000 $
5 079 000 $
7 094 000 $
8 106 000 $
5 434 000 $
6 825 000 $
5 288 000 $
6 302 000 $
5 726 000 $
240 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
6 065 000 $
5 651 000 $
6 776 000 $
6 743 000 $
4 824 000 $
5 654 000 $
4 594 000 $
3 816 000 $
3 967 000 $
3 625 000 $
4 259 000 $
4 222 000 $
4 496 000 $
4 462 000 $
3 906 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
53 022 000 $
55 979 000 $
52 124 000 $
54 388 000 $
40 245 000 $
43 283 000 $
39 524 000 $
39 025 000 $
40 340 000 $
41 414 000 $
40 921 000 $
25 438 000 $
22 242 000 $
21 848 000 $
20 265 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
188 294 000 $
177 616 000 $
162 190 000 $
174 206 000 $
152 432 000 $
144 761 000 $
137 389 000 $
144 665 000 $
139 614 000 $
139 053 000 $
140 243 000 $
139 472 000 $
136 617 000 $
133 875 000 $
129 167 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
439 169 000 $
423 930 000 $
405 261 000 $
419 787 000 $
338 128 000 $
325 478 000 $
322 436 000 $
253 964 000 $
249 857 000 $
251 377 000 $
253 983 000 $
254 547 000 $
251 951 000 $
249 777 000 $
245 143 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
63 374 000 $
63 193 000 $
53 514 000 $
63 445 000 $
68 557 000 $
62 397 000 $
55 192 000 $
66 097 000 $
61 523 000 $
59 763 000 $
57 930 000 $
56 400 000 $
54 711 000 $
57 072 000 $
55 253 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
34 853 000 $
20 914 000 $
19 822 000 $
24 082 000 $
20 690 000 $
24 173 000 $
24 465 000 $
4 500 000 $
4 500 000 $
4 500 000 $
4 500 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
-
56 400 000 $
54 711 000 $
57 072 000 $
55 253 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
140 836 000 $
134 511 000 $
133 883 000 $
72 319 000 $
71 215 000 $
75 959 000 $
78 856 000 $
52 414 000 $
53 530 000 $
54 647 000 $
55 763 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
41.65 %
41.33 %
41.52 %
28.48 %
28.50 %
30.22 %
31.05 %
20.59 %
21.25 %
21.88 %
22.75 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
309 473 000 $
278 867 000 $
247 629 000 $
233 335 000 $
197 292 000 $
190 967 000 $
188 553 000 $
181 645 000 $
178 642 000 $
175 418 000 $
175 127 000 $
174 336 000 $
172 878 000 $
169 585 000 $
167 549 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
5 288 000 $
7 485 000 $
7 376 000 $
11 563 000 $
9 407 000 $
11 201 000 $
9 743 000 $
8 668 000 $
5 171 000 $
8 864 000 $
7 359 000 $
Last revenue report of Meridian Bioscience, Inc. was 31/03/2021. According to last financial report total revenue in Meridian Bioscience, Inc. was 85 264 000 US dollar and changed by +69.69% since last year. Net income in Meridian Bioscience, Inc. was 26 302 000 $ in last quartal, net income changes to +270.76%.
Current cash Meridian Bioscience, Inc. - the sum of all of the cash a company has on the date of report. Current cash Meridian Bioscience, Inc. is 63 374 000 $
Meridian Bioscience, Inc. stocks data
VIVO stock price
Meridian Bioscience, Inc. stock price today, VIVO stock quote.
